Ann: MYX signs license agreement for women's health products, page-108

Yeah sounds great . 75-80% is about standard
for exclusive products. Doryx; Nuvaring; Nextellis;
even other secret products. The theory reads well.
TherapeuticsMD up 40% Mayne down 50%.
These are the facts. I have been in exactly your
position before Deb.Over the years this company
has misled retail shareholders to the extreme whilst
senior management have done very well. This decision
deal appears very sudden to me particularly since
chair considered buyback. I just wonder about Due
Diligence. Was there enough time ? Seriously considering the financial situation TMD we’re in couldn’t
we have waited longer. We held the winning hand
Cash $$$$. We didn’t do their chief Tommy Thompson a
huge favour did we ? These CEOs of Pharmaceutical
companies seem to have cosy relationships. I know I
seem cynical, it’s because I am. The previous CEO
Richards I wouldn’t trust out of sight.